Publication year
2007Author(s)
Source
British Journal of Clinical Pharmacology, 63, 3, (2007), pp. 258-267ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Clinical Pharmacy
Journal title
British Journal of Clinical Pharmacology
Volume
vol. 63
Issue
iss. 3
Page start
p. 258
Page end
p. 267
Subject
CTR 2: Clinical Pharmacology and physiology; EBP 4: Quality of Care; N4i 1: Pathogenesis and modulation of inflammation; N4i 3: Poverty-related infectious diseases; NCEBP 3: Implementation Science; UMCN 3.2: Cognitive neurosciences; CTR 2: Clinical Pharmacology and physiologyAbstract
The concomitant use of conventional and herbal medicines can lead to clinically relevant herb-drug interactions. Clinical risk management offers a systematic approach to minimize the untoward consequences of these interactions by paying attention to: (i) risk identification and assessment; (ii) development and execution of risk reduction strategies; and (iii) evaluation of risk reduction strategies. This paper reviews which steps should be explored or taken in these domains to improve the clinical risk management of adverse herb-drug interactions.
This item appears in the following Collection(s)
- Academic publications [204980]
- Faculty of Medical Sciences [81051]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.